SCORE DE LICHTIGER [329]

Critères Score

Diarrhée (nombre de selles par 24h) 0-2 3-4 5-6 7-9 10 0 1 2 3 4 Diarrhée nocturne Non Oui 0 1

Rectorragies visibles (% de nombre de selles) 0 <50% >50% 100% 0 1 2 3 Incontinence fécale Non Oui 0 1

Douleurs abdominales Non Minimes Modérées Sévères 0 1 2 3 Etat général Parfait Très bon Bon Moyen Mauvais Très mauvais 0 1 2 3 4 5 Tension abdominale Non Minime / Localisée

Minime à modérée / Diffuse Sévère / Tendue 0 1 2 3 Traitement antidiarrhéique Non 0

[1] Morgagni GB. Seat and causes of diseases. Book III, Letter XXXI, Article 2. Published under the auspices of the Library of the New York Academy of Medicine, New York, Hafner Publishing, 1960, vol. 2, p 64.

[2] Dalziel TK. Chronic interstitial enteritis. British Medical Journal 2, 1913:1068-70.

[3] Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. Journal of the American Medical Association 99:1323-28, 1932.

[4] Colp R. A case of non-specific granuloma of the terminal ileum and

cecum. Surgical Clinics of North America 14:443-449, 1934.

[5] Wells C. Ulcerative colitis and Crohn's disease. Annals of the Royal College of Surgeons of England 11:105-120, 1952.

[6] Lockhart-Mummery HE, Morson BC. Crohn's disease (regional

enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1:87-105, 1960.

[7] Bissell AD. Localized chronic ulcerative ileitis. Annals of Surgery 99:957-966, 1934.

[8] Gottlieb L, Alpert S. Regional jejunitis. The American Journal of Reontgenology, Radium Therapy and Nuclear Medicine 38:881-883, 1937.

[10] Franklin R, Taylor S. Nonspecific granulomatous (regional)

esophagitis. The Journal of Thoracic Surgery 19:292-297, 1950.

[11] Dudeney T. Crohn's disease of the mouth. Proceedings of the Royal Society of Medicine 62:1237, 1969.

[12] Ginzburg L. Operative procedures upon the small intestine.

Chapitre à The surgical technique of Dr A. A. Berg : A tribute to forty years' service at the Mount Sinai Hospital. New York, Mount

Sinai Hospital, 1934, p 28-43.

[13] Garlock GH, Crohn BB. An appraisal of the results of surgery in

treatment of regional ileitis. Journal of the American Medical

Association 127:205-208, 1945.

[14] Aufses AH Jr. The history of Crohn's disease. The Surgical Clinics of North America 2001 Feb; 81(1):1-11, vii.

[15] Lee ECG, Papaioannou N. Minimal surgery for chronic obstruction

in patients with extensive or universal Crohn's disease. Annals of

the Royal College of Surgeons of England 64:229-233, 1982.

[16] Katariya RN, Sood S, Rao PG. Strictureplasty for tubercular

strictures of the gastrointestinal tract. British Journal of Surgery

64:496, 1977.

[17] Alexander-Williams J. Historical review. Cité par Allan R, Rhodes JM, Hanauer SB, et al : Inflammatory bowel disease. London, Churchill Livingstone 1996, pp3-12.

[18] Ozuner G, Fazio VX, Lavery IC, et al. How safe is strictureplasty in

the management of Crohn's disease ? The American Journal of

Surgery 171:57-60, 1996.

[19] Ozuner G, Fazio VX, Lavery IC, et al. Reoperative rates for Crohn's

disease following strictureplasty : Long-term analysis. Diseases of

the Colon and Rectum 39:1199-1203, 1996.

[20] Stebbing J, Jewell DP, Kettlewell MG, et al. Recurrence and

reoperation after strictureplasty for obstructive Crohn's disease : Long-term results. British Journal of Surgery 82:1471-74, 1995.

[21] Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and

natural history of inflammatory bowel disease. Gastroenterology

2011;140(6):1785-94.

[22] Malik TA. Inflammatory bowel disease : Historical perspective,

epidemiology and risk factors. Surgical Clinics of North America

2015 dec;95(6):1105-22, v.

[23] Burisch J, Jess T, Martinato M, Lakatos PL. The burden of

inflammatory bowel disease in Europe. Journal of Crohn's and

Colitis 2013;7:322-337.

[24] Burisch J, Pedersen N, Čukovič-Čavka S, Brinar M, Kaimakliotis I, Duricova D, et al. East-West gradient in the incidence of

[25] Yapp TR, Stenson R, Thomas GA, et al. Crohn’s disease incidence in

Cardiff from 1930: an update for 1991-1995. European Journal of

Gastroenterology and Hepatology 2000;12:907–911.

[26] Rubin GP, Hungin AP, Kelly PJ, et al. Inflammatory bowel disease :

epidemiology and management in an English general practice population. Alimentary Pharmacology and Therapeutics 2000;14:1553-59.

[27] Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence

and prevalence of Crohn's disease and ulcerative colitis in Olmsted Country, Minnesota from 1970 through 2010. Clinical Gastroenterology and Hepatology 2016 Nov 14.

[28] Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of

inflammatory bowel disease in Canada: a population-based study.

The American Journal of Gastroenterology 2006;101:1559-68.

[29] Ng SC, Tang W, Ching JY, Wong M, et al. Incidence and phenotype

of inflammatory bowel disease based en results from the Asia-pacific Crohn's and colitisepidemiology study. Gastroenterology

2013;145:158-65, e2.

[30] Farrukh A, Mayberry JF. Epidemiology of inflammatory bowel

disease in the Middle-East - An opportune time. The Arab Journal

of Gastroenterology Sep-Dec 15(3-4):163-165.

[31] Krati K, Cherquaoui H. Prise en charge de la maladie de Crohn

fistulisante dans une population marocaine : A propos de 78 cas.

[32] Elazzaoui Z, Ibrahimi SA, Ennofous Kraimi H, et al. Les aspects

épidemiologiques des MICI dans une population marocaine : A propos de 300 cas. Thèse N°143/2012, Fès.

[33] Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of

inflammatory bowel disease in Japan : Nationwide epidemiological survey during the year 1991. Journal of Gastroenterology

1995;30(Suppl 8):1-4.

[34] Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory

bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005 : A KASID study. Inflammatory Bowel Diseases

2008;14:542-549.

[35] Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, et al.

Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World Journal of Gastroenterology 2004 May

1;10(9):1341-1344.

[36] Qabandi WA, Buhamrah EK, Hamadi KA, Osaimi SA, Al-Ruwayeh AA, Madda J. Inflammatory bowel disease in children, an

evolving problem in Kuwait. Saudi Journal of Gastroenterology

2011;17:323-327.

[37] Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, et al. Clinical characteristics of inflammatory bowel disease in

[38] Abdul-Baki H, ElHaji I, El-Zahabi LM, Azar C, Aoun E, Zantout H, et al. Clinican epidemiology of inflammatory bowel disease in

Lebanon. Inflammatory Bowel Diseases 2007; 13:475-480.

[39] Hammada T, Lemdaoui MC, Boutra F, et al. Aspects épidémiologiques des maladies inflammatoires chroniques de l'intestin dans une population algérienne. Journal Africain

d'Hépato-Gastroentérologie 2011 (5):293-302.

[40] Zahedi MJ, Moghadam SD, Abbasi MHB, Dehghani M, Shafiei S, Zydabady H, et al. The incidence rate of inflammatory bowel

disease in an urban area of Iran : A developing country. Middle

East Journal of Digestive Diseases 2014;6:32-36.

[41] Vegh Z, Burisch J, Pederson N, Kaimakliotis I, et al. Incidence and

initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia : Results of the 2011 ECCO-EpiCom inception cohort. Journal of Crohn's and Colitis 2014 Nov;8(11):1505-1515.

[42] Diefenbach K, Breuer C. Pediatric inflammatory bowel disease. World Journal of Gastroenterology 2006 May 28;12(20):3204-12. [43] Rabizadeh S, Dubinsky M. Update in pediatric inflammatory bowel

disease. Rheumatic Disease Clinics of North America 2013

Nov;39(4):789-799.

[44] Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel

[45] Kugathasan S, Fiocchi C. Progress in basic inflammatory bowel

disease research. Seminars is Pediatric Surgery 2007;16:146-153.

[46] Podolsky DK. Inflammatory bowel disease. The New England Journal of Medicine 2002;347:417-429.

[47] Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking

and inflammatory bowel disease : A meta-analysis. Mayo Clinic

Proceedings 2006;8:1462-71.

[48] Calkins BM. A meta-analysis of the role of smoking in

inflammatory bowel disease. Digestive Diseases and Sciences

1989;34:1841-54.

[49] Cosnes J, Nion-Larmurier I, Afchain P, Beau-gerie L, Gendre JP.

Gender differences in the response of colitis to smoking. Clinical

Gastroenterology and Hepatology 2004;2:41-48.

[50] Nos P, Domènech E. Management of Crohn’s disease in smokers: Is

an alternative approach necessary ? World Journal of

Gastroenterology 2011;17:3567-74.

[51] Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS. A prospective study of cigarette smoking and the risk of

inflammatory bowel disease in women. The American Journal of

Gastroenterology 2012;107:1399-1406.

[52] Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel

[53] Lunney PC, Kariyawasam VC, Wang RR, Middleton KL, Huang T, Selinger CP, Andrews JM, Katelaris PH, Leong RW. Smoking

prevalence and its influence on disease course and surgery in Crohn’s disease and ulcerative colitis. Alimentary Pharmacology and

Therapeutics 2015;42: 61-70.

[54] Picco MF, Bayless TM. Tobacco consumption and disease duration

are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. The American Journal of

Gastroenterology 2003;98:363-368.

[55] Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking

in Crohn’s disease as defined by clinical variables. Digestive

Diseases and Sciences 2007;52:2897-2903.

[56] Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn’s disease: A

meta-analysis of observational studies. International Journal of

Colorectal Disease 2008;23:1213-21.

[57] van der Heide F, Dijkstra A, Weersma RK, Albersnagel FA, van der Logt EM, Faber KN, Sluiter WJ, Kleibeuker JH, Dijkstra G. Effects of

active and passive smoking on disease course of Crohn’s disease and ulcerative colitis. Inflammatory Bowel Diseases

2009;15:1199-1207.

[58] Johnson GJ, Cosnes J, Mansfield JC. Review article : Smoking

cessation as primary therapy to modify the course of Crohn’s disease. Alimentary Pharmacology and Therapeutics 2005;21:921-931.